CADTH endorses that public drug programs reimburse Hemgenix for the treatment method of hemophilia B if sure situations are fulfilled.As for all medicines, knowledge on the use of Hemgenix are continuously monitored. Suspected Negative effects documented with Hemgenix are very carefully evaluated and any essential motion taken to safeguard patients